{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:50:23Z","timestamp":1782222623975,"version":"3.54.5"},"reference-count":26,"publisher":"Japan Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1507\/endocrj.ej16-0500","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T22:08:51Z","timestamp":1484863731000},"page":"339-346","source":"Crossref","is-referenced-by-count":30,"title":["Aldosterone excess may inhibit insulin secretion: A comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism"],"prefix":"10.1507","volume":"64","author":[{"given":"Yuya","family":"Tsurutani","sequence":"first","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama 222-0036, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiho","family":"Sugisawa","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama 222-0036, Japan"},{"name":"Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama 227-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Ishida","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama 222-0036, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Inoue","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama 222-0036, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Saito","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama 222-0036, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Omura","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama 222-0036, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Nagasaka","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama 227-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama 222-0036, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, <i>et al<\/i>. (2008) Cardiovascular outcomes in patients with primary aldosteronism after treatment. <i>Arch Intern Med<\/i> 168: 80-85.","DOI":"10.1001\/archinternmed.2007.33"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Milliez P, Girerd X, Plouin P-F, Blacher J, Safar ME, <i>et al<\/i>. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. <i>J Am Coll Cardiol<\/i> 45: 1243-1248.","DOI":"10.1016\/j.jacc.2005.01.015"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, <i>et al<\/i>. (2009) Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: Results of the German Conn&rsquo;s registry. <i>J Clin Endocrinol Metab<\/i> 94: 1125-1130.","DOI":"10.1210\/jc.2008-2116"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. American Diabetes Association (2014) Diagnosis and Classification of Diabetes Mellitus. <i>Diabetes Care<\/i> 37 Suppl 1: S81-90.","DOI":"10.2337\/dc14-S081"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chen F, Liu J, Wang Y, Wu T, Shan W, <i>et al<\/i>. (2015) Aldosterone induces clonal &beta;-cell failure through glucocorticoid receptor. <i>Sci Rep<\/i> 5: 13215.","DOI":"10.1038\/srep13215"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi G, <i>et al<\/i>. (2006) Insulin sensitivity in patients with primary aldosteronism: a follow-up study. <i>J Clin Endocrinol Metab<\/i> 91: 3457-3463.","DOI":"10.1210\/jc.2006-0736"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fischer E, Adolf C, Pallauf A, Then C, Bidlingmaier M, <i>et al<\/i>. (2013) Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. <i>J Clin Endocrinol Metab<\/i> 98: 2513-2520.","DOI":"10.1210\/jc.2012-3934"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, <i>et al<\/i>. (2011) Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009. <i>Endocr J <\/i>58: 711-721.","DOI":"10.1507\/endocrj.EJ11-0133"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nishikawa T (2002) Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. <i>Metabolism<\/i> 51: 350-355.","DOI":"10.1053\/meta.2002.30498"},{"key":"10","unstructured":"10. Omura M, Nishikawa T (2006) Screening tests and diagnostic examinations of hypertensives for primary aldosteronism. <i>Rinsho Byori<\/i> 54: 1157-1163 (In Japanese)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, <i>et al<\/i>. (2006) Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism.<i> Hypertens Res<\/i> 29: 883-889.","DOI":"10.1291\/hypres.29.883"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kitamoto T, Suematsu S, Yamazaki Y, Nakamura Y, Sasano H, <i>et al<\/i>. (2016) Clinical and steroidogenic characteristics of aldosterone-producing adenomas with ATPase or CACNA1D gene mutations. <i>J Clin Endocrinol Metab<\/i> 101: 494-503.","DOI":"10.1210\/jc.2015-3284"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus, Seino Y, Nanjo K, Tajima N, Kadowaki T, <i>et al<\/i>. (2010) Report of the committee on the classification and diagnostic criteria of diabetes mellitus. <i>J Diabetes Investig<\/i> 1: 212-228.","DOI":"10.1111\/j.2040-1124.2010.00074.x"},{"key":"14","unstructured":"14. Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing&rsquo;s syndrome and pseudo-Cushing&rsquo;s states. <i>Endocr Rev<\/i> 19: 647-672."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Soyama A, Nishikawa T, Ishizuka T, Ito H, Saito J, <i>et al<\/i>. (2005) Clinical usefulness of the thickness of preperitoneal and subcutaneous fat layer in the abdomen estimated by ultrasonography for diagnosing abdominal obesity in each type of impaired glucose tolerance in man. <i>Endocr J<\/i> 52: 229-236.","DOI":"10.1507\/endocrj.52.229"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Phillips DI, Clark PM, Hales CN, Osmond C (1994) Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. <i>Diabet Med<\/i> 11: 286-292.","DOI":"10.1111\/j.1464-5491.1994.tb00273.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, <i>et al<\/i>. (1985) Homeostasis model assessment: insulin resistance and &beta;-cell function from fasting plasma glucose and insulin concentrations in man. <i>Diabetologia<\/i> 28: 412-419.","DOI":"10.1007\/BF00280883"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp.<i> Diabetes Care<\/i> 22: 1462-1470.","DOI":"10.2337\/diacare.22.9.1462"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sato Y, Oka R, Nakasone Y, Katakura M, Yamauchi K, <i>et al<\/i>. (2015) Impact of one-hour postchallenge glucose on the relationship between insulin sensitivity and secretion. <i>Endocr J<\/i> 62: 573-583.","DOI":"10.1507\/endocrj.EJ15-0122"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-J&auml;rvinen H, <i>et al<\/i>. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. <i>Diabetes Care<\/i> 23: 295-301.","DOI":"10.2337\/diacare.23.3.295"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Henquin JC (2009) Regulation of insulin secretion: A matter of phase control and amplitude modulation. <i>Diabetologia<\/i> 52: 739-751.","DOI":"10.1007\/s00125-009-1314-y"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Luther JM, Luo P, Kreger MT, Brissova M, Dai C, <i>et al<\/i>. (2011) Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. <i>Diabetologia<\/i> 54: 2152-2163.","DOI":"10.1007\/s00125-011-2158-9"},{"key":"23","unstructured":"23. Sindelka G, Widimsky J, Haas T, Prazny M, Hilgertova J, <i>et al<\/i>. (2000) Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment. <i>Exp Clin Endocrinol Diabetes<\/i> 108: 21-25."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, <i>et al<\/i>. (2007) Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. <i>J Hypertens<\/i> 25: 177-186.","DOI":"10.1097\/HJH.0b013e3280108e6f"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Laakso M, Edelman SV, Brechtel G, Baron AD (1990) Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. <i>J Clin Invest<\/i> 85: 1844-1852.","DOI":"10.1172\/JCI114644"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Laakso M, Edelman SV, Brechtel G, Baron AD (1992) Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. <i>Diabetes<\/i> 41: 1076-1083.","DOI":"10.2337\/diab.41.9.1076"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/3\/64_EJ16-0500\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T19:27:11Z","timestamp":1568748431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/3\/64_EJ16-0500\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej16-0500","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}